Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
Work
Year: 2015
Type: article
Abstract: Background and Purpose Cannabidiol has been reported to act as an antagonist at cannabinoid CB 1 receptors. We hypothesized that cannabidiol would inhibit cannabinoid agonist activity through negative... more
Source: British Journal of Pharmacology
Institution Dalhousie University
Cites: 47
Cited by: 854
Related to: 10
FWCI: 32.08
Citation percentile (by year/subfield): 99.99
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze